Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nafziger

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Annales Pharmaceutiques Francaises|January 1, 1983
[The action of various antiadrenergic substances on the liberation of the growth factor (CSA) for granulo-monocytic lines]J Nafziger, N Kouja, M Debray, et al.
Mutation Research|October 1, 1995
A new anthracycline with potent antileukemic activity exhibits reduced mutagenicityW Andrivon, F Callais, J Nafziger, et al.
Annales Pharmaceutiques Francaises|January 1, 1981
[Peritoneal fluid colony stimulating activity (CSA) release after Escherichia coli endotoxin infection (author's transl)]J Nafziger, M Adolphe, J J Guillosson, et al.
Cancer Research|February 1, 1985
Flow cytometric analysis of pentakis(aziridino)thiatriazadiphosphorine oxide (SOAz)-induced changes in cell cycle progression of HeLa and HL-60 cellsC Hecquet, J Nafziger, X Ronot, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1973
[Copper metabolism in rheumatoid arthritis and influence of D-penicillamine treatment]J Crouzet, J Nafziger, P Guillien, et al.
Leukemia Research|January 1, 1991
Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activityJ Nafziger, C Auclair, J C Florent, et al.
Gerontology|January 1, 1997
Factors involved in the anaemia of chronic disorders in elderly patientsL Piéroni, M J Foglietti, J P Andreux, et al.
Leukemia Research|July 29, 1998
A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistanceW Andrivon, C Monneret, J Nafziger, et al.
Anesthesie, Analgesie, Reanimation|September 1, 1974
[Serum pseudocholinesterases. Preliminary study]M T Cousin, C Conseiller, J J Guillosson, et al.
Life Sciences|January 1, 1997
Investigation of the effects of 50 Hz magnetic fields on purified human hematopoietic progenitorsJ Nafziger, L Devevey, V Tricottet, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Annales Pharmaceutiques Francaises|January 1, 1983
[The action of various antiadrenergic substances on the liberation of the growth factor (CSA) for granulo-monocytic lines]J Nafziger, N Kouja, M Debray, et al.
Mutation Research|October 1, 1995
A new anthracycline with potent antileukemic activity exhibits reduced mutagenicityW Andrivon, F Callais, J Nafziger, et al.
Annales Pharmaceutiques Francaises|January 1, 1981
[Peritoneal fluid colony stimulating activity (CSA) release after Escherichia coli endotoxin infection (author's transl)]J Nafziger, M Adolphe, J J Guillosson, et al.
Cancer Research|February 1, 1985
Flow cytometric analysis of pentakis(aziridino)thiatriazadiphosphorine oxide (SOAz)-induced changes in cell cycle progression of HeLa and HL-60 cellsC Hecquet, J Nafziger, X Ronot, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1973
[Copper metabolism in rheumatoid arthritis and influence of D-penicillamine treatment]J Crouzet, J Nafziger, P Guillien, et al.
Leukemia Research|January 1, 1991
Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activityJ Nafziger, C Auclair, J C Florent, et al.
Gerontology|January 1, 1997
Factors involved in the anaemia of chronic disorders in elderly patientsL Piéroni, M J Foglietti, J P Andreux, et al.
Leukemia Research|July 29, 1998
A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistanceW Andrivon, C Monneret, J Nafziger, et al.
Anesthesie, Analgesie, Reanimation|September 1, 1974
[Serum pseudocholinesterases. Preliminary study]M T Cousin, C Conseiller, J J Guillosson, et al.
Life Sciences|January 1, 1997
Investigation of the effects of 50 Hz magnetic fields on purified human hematopoietic progenitorsJ Nafziger, L Devevey, V Tricottet, et al.
Pageof 5